title: Determining equivalence of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at Royal Brompton National Heart & Lung Institute, London 24 June 1994.
authors.affiliation: Department of Thoracic Medicine, National Heart & Lung Institute, London, U.K.
authors.forename: D F
authors.initials: DF
authors.lastname: Rogers
authors.forename: D
authors.initials: D
authors.lastname: Ganderton
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D000336:Aerosols; D000368:Aged; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002648:Child; D004335:Drug and Narcotic Control; D005938:Glucocorticoids / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D009330:Nebulizers and Vaporizers; D011877:Radionuclide Imaging; D013501:Surface-Active Agents / Q000009:adverse effects; D013810:Therapeutic Equivalency; D006113:United Kingdom
chemical_list: D000336:Aerosols; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D013501:Surface-Active Agents